Event Highlights - September 11, 2025
Implementing the EU health technology assessment in Norway: Insights from industry leaders
A roundtable discussion hosted by PharmaLex and The Life Science Cluster in Norway on 14 May 2025, brought together pharmaceutical companies and industry experts to discuss the implications of the European Union’s Joint Clinical Assessment (JCA) process under the Health Technology Assessment Regulation (HTAR).